Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingxia Liu

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
Journal of Clinical and Translational Hepatology|October 28, 2022
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)Zhihua Liu, Zhongdan Chen, Fuqiang Cui, et al.
Mbio|August 9, 2018
Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell ResponsesMin Zhao, Kefang Liu, Jiejian Luo, et al.
Respiratory Research|July 10, 2021
Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort studyXiaohe Li, Chenguang Shen, Lifei Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2024
Structure and function of <i>Mycobacterium tuberculosis</i> EfpA as a lipid transporter and its inhibition by BRD-8000.3Delin Li, Xiaokang Zhang, Yuanhang Yao, et al.
Annals of Translational Medicine|November 4, 2020
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA testJianghong An, Xuejiao Liao, Tongyang Xiao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2020
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Juanjuan Zhao, Quan Yuan, Haiyan Wang, et al.
Journal of Virology|March 23, 2018
New Threats from H7N9 Influenza Virus: Spread and Evolution of High- and Low-Pathogenicity Variants with High Genomic Diversity in Wave FiveChuansong Quan, Weifeng Shi, Yang Yang, et al.
International Immunopharmacology|April 30, 2021
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trialHong Zhao, Chi Zhang, Qi Zhu, et al.
Science (New York, N.Y.)|May 15, 2020
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Yan Wu, Feiran Wang, Chenguang Shen, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2020
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19Yang Yang, Chenguang Shen, Jinxiu Li, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Journal of Clinical and Translational Hepatology|October 28, 2022
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)Zhihua Liu, Zhongdan Chen, Fuqiang Cui, et al.
Mbio|August 9, 2018
Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell ResponsesMin Zhao, Kefang Liu, Jiejian Luo, et al.
Respiratory Research|July 10, 2021
Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort studyXiaohe Li, Chenguang Shen, Lifei Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2024
Structure and function of <i>Mycobacterium tuberculosis</i> EfpA as a lipid transporter and its inhibition by BRD-8000.3Delin Li, Xiaokang Zhang, Yuanhang Yao, et al.
Annals of Translational Medicine|November 4, 2020
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA testJianghong An, Xuejiao Liao, Tongyang Xiao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2020
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Juanjuan Zhao, Quan Yuan, Haiyan Wang, et al.
Journal of Virology|March 23, 2018
New Threats from H7N9 Influenza Virus: Spread and Evolution of High- and Low-Pathogenicity Variants with High Genomic Diversity in Wave FiveChuansong Quan, Weifeng Shi, Yang Yang, et al.
International Immunopharmacology|April 30, 2021
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trialHong Zhao, Chi Zhang, Qi Zhu, et al.
Science (New York, N.Y.)|May 15, 2020
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Yan Wu, Feiran Wang, Chenguang Shen, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2020
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19Yang Yang, Chenguang Shen, Jinxiu Li, et al.
Pageof 22